Antibody-drug conjugates (ADCs) have fundamentally transformed the landscape of modern oncology, offering a sophisticated "seek-and-destroy" mechanism that couples the precision…
Read More
FDA greenlights ViiV Healthcare’s Tivicay PD for HIV-positive newborns in first month of life
The U.S. Food and Drug Administration (FDA) has officially granted approval for ViiV Healthcare’s Tivicay PD (dolutegravir) to treat HIV-1…
Read More
Negative Pressure, Positive Lab Safety
The fundamental mechanics of laboratory safety often remain invisible to the naked eye, yet the strategic management of airflow serves…
Read More
GSK Secures US Approval for Jideytro in ROS1-Positive Lung Cancer, Entering Competitive Market
Just days after finalizing a monumental $10.6 billion acquisition of Nuvalent, a move that significantly bolsters its oncology pipeline, GlaxoSmithKline…
Read More
J&J raises FY26 outlook following positive Q2 – Pharmaceutical Technology
Johnson & Johnson (J&J) announced robust second-quarter (Q2) revenues totaling approximately $25.3 billion, marking a significant 6.6% increase year-over-year (YoY).…
Read More
Yale Study Reveals That Significant Cognitive and Physical Gains Are Common in Older Adults Driven by Positive Beliefs About Aging
The traditional narrative of aging has long been characterized as a period of inevitable and irreversible decline, where both the…
Read More
ASCO 2026: Kelonia presents positive in vivo CAR-T data in multiple myeloma – Pharmaceutical Technology
The rapidly evolving landscape of multiple myeloma treatment is witnessing a pivotal moment with the emergence of in vivo chimeric…
Read More
Novo Nordisk’s Wegovy Poised for Significant European Expansion Following Positive CHMP Opinions on Oral and High-Dose Injectable Formulations
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has delivered two pivotal positive opinions, paving…
Read More
European Commission Approves Keytruda Combination Therapy for PD-L1-Positive Platinum-Resistant Ovarian Cancer
The European Commission (EC) has granted approval for Keytruda (pembrolizumab) in combination with paclitaxel, with or without bevacizumab, as a…
Read More
